Open AccessTHE EFFECTIVENESS OF COMBINED TREATMENT OF DISSEMINATED MALIGNANT PLEURAL MESOTHELIOMA, A DESCRIPTION OF THE CLINICAL CASE
Author(s) -
T.D. Karpenko,
М. Б. Бычков
Publication year - 2017
Publication title -
rossijskij onkologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2412-9119
pISSN - 1028-9984
DOI - 10.18821/1028-9984-2017-22-5-274-276
Subject(s) - pemetrexed , medicine , mesothelioma , medical prescription , intensive care medicine , oncology , pleural disease , disease , stage (stratigraphy) , disease control , surgery , chemotherapy , respiratory disease , pathology , lung , cisplatin , pharmacology , paleontology , virology , biology
Modern approach to the individualization of the management of patients based on the careful observation for the minimal manifestations of the disease, prescription of pemetrexed at the first line of therapy, combination with platinum preparations and antiangiogenic targeted preparation bevazisumab allows control the disease at the advanced stage of pleural mezoteliom and support the good active state of patients during the long time.